IAC/InterActiveCorp (NASDAQ:IACI) begin trading ex-dividend on November 12, 2014. A cash dividend payment of $0.34 per share is scheduled to be paid on December 01, 2014. Shareholders who purchased IACI stock prior to the ex-dividend date are eligible for the cash dividend payment. IAC/InterActiveCorp (NASDAQ:IACI) in last trading activity advanced 1.35% to close at $65.87. Company weekly performance is 1.54% while its quarterly performance stands at -3.83%. IAC/InterActiveCorp (NASDAQ:IACI) is -17.15% away from its 52 week high.
KeyCorp (NYSE:KEY) has received a “BBB+” credit rating from Morningstar. The firm’s “BBB+” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating. On last trading day KeyCorp. (NYSE:KEY) advanced 2.19% to close at $13.53. Its volatility for the week is 1.53% while volatility for the month is 1.36%. KEY’s sales growth for past 5 years was -9.70% and its EPS growth for past 5 years was 18.30%. KeyCorp. (NYSE:KEY) monthly performance is 5.79%.
On Nov. 13, Nacco Industries Inc. (NYSE:NC) announced that the Board of Directors declared a regular cash dividend of 25.75 cents per share. The dividend is payable on both the Class A and Class B Common Stock, and will be paid December 15, 2014 to stockholders of record at the close of business on December 1, 2014. On last trading day Nacco Industries Inc. (NYSE:NC) advanced 1.52% to close at $60.28. Its volatility for the week is 2.07% while volatility for the month is 3.73%. NC’s sales growth for past 5 years was -23.90% and its EPS growth for past 5 years was 16.00%. Nacco Industries Inc. (NYSE:NC) monthly performance is 15.68%.
Zacks cut shares of Alliance Fiber Optic Products (NASDAQ:AFOP) from a neutral rating to an underperform rating in a research note issued to investors on Tuesday. The firm currently has $12.70 price target on the stock . Alliance Fiber Optic Products Inc. (NASDAQ:AFOP) has 8.00% insider ownership while its institutional ownership stands at 37.50%. In last trading activity company’s stock closed at $12.87.
On Nov. 10, TG Therapeutics, Inc. (NASDAQ:TGTX) announced its results for the third quarter ended September 30, 2014 and recent company developments. At September 30, 2014 the Company had cash, cash equivalents, investment securities, and interest receivable of $67.3 million, which includes approximately $22.8 million of net proceeds from the utilization of the Company’s at-the-market (“ATM”) sales facility during the third quarter, as compared to $45.4 million at December 31, 2013. On Monday shares of TG Therapeutics, Inc. (NASDAQ:TGTX) closed at $15.13.